The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s pharmaceutical API manufacturing market report forecasts the pharmaceutical API manufacturing market size to grow to $266.72 Billion by 2027, with a CAGR (compound annual growth rate) of more than 6%.

Learn More On The Pharmaceutical API Manufacturing Market Report 2023 – https://www.thebusinessresearchcompany.com/report/pharmaceutical-api-manufacturing-global-market-report

Pharmaceutical API Manufacturing Market Size Forecast
The global pharmaceutical API manufacturing market is expected to grow from $195.29 billion in 2022 to $209.93 billion in 2023 at a compound annual growth rate (CAGR) of 7.5%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The pharmaceutical API manufacturing market is expected to grow from $266.72 billion in 2027 at a CAGR of 6.2%.

North America held the largest pharmaceutical API manufacturing market share, and Middle East was the fastest-growing region in 2022.

Key Pharmaceutical API Manufacturing Market Driver ­– Rise In The Aging Population
For instance, in October 2022, according to an article shared by WHO, a Switzerland-based specialized agency of the United Nations responsible for international public health, 80% of senior citizens will reside in low- and middle-income nations by 2050. The population is aging considerably more quickly than in the past. In 2020, there will be more persons over the age of 60 than under five-year-olds. Therefore, rise in aging population is driving the growth of the pharmaceutical API manufacturing market.

Request for A Sample Of The Global Pharmaceutical API Manufacturing Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2467&type=smp

Key Pharmaceutical API Manufacturing Market Trend – Adopting Modern Technologies
Many companies use modern technologies such as process control, and powder handling to optimize API manufacturing. These technologies include advances in Lyophilization i.e. freeze-drying process. It is a low-temperature dehydration process that involves freezing the product, lowering pressure, and then removing the ice formed. For instance, Telstar, a company that manufactures efficient integrated systems for pharmaceutical and manufacturing processes, developed LyoGistics Zero, automatic loading and unloading system for freeze dryers to manufacture hazardous products. The system uses a linear magnetic driving mechanism that functions without racks and belts to reduce particle generation and this improves the hygiene in API manufacturing. Also, ILC Dover, a pharmaceutical company, developed the JetBreaker system, a semi-automatic powder handling system that separates powdered media and buffers powders so that they can be mixed better in a solution.

Pharmaceutical API Manufacturing Market Segment
1) By Therapy Area: Cardiovascular disorders, Metabolic disorders, Neurological disorders, Oncology, Musculoskeletal disorders, NSAIDs, Other therapeutics uses
2) By API Type: Chemical API, Biological API
3) By Drug Type: Innovative Drugs, Generic Prescription, Over-the-counter (OTC) Drugs

Pharmaceutical API Manufacturing Market Major Players and Strategies
Major players in the pharmaceutical API manufacturing market are Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Boehringer Ingelheim, PfizerInc., Aurobindo Pharma, Novartis AG, Dr. Reddy’s Laboratories, Merck & Co.Inc., BASF SE., Bayer Healthcare, Mylan N.V., Albemarle Corporation, Actavis PLC., Hospira Inc., Ranbaxy Laboratories, Virbac, Zoetis, Heska Co., AbbVie Inc., AstraZeneca PLC., Eli Lilly and Company, GlaxoSmithKline PLC., Sanofi, Bristol-Myers Squibb, CiplaInc., and F. Hoffmann-La Roche Ltd.

In March 2021, Piramal Pharma Ltd., an India-based healthcare solutions company, acquired Hemmo Pharmaceuticals for an amount of $105.8 million. This acquisition is expected to expand PPS’s capacity to provide integrated services to its clients globally by gaining access to the expanding peptide API industry. The deal would also increase peptide API manufacturing and development capabilities. Hemmo Pharmaceuticals is an India-based developer and manufacturer of peptide APIs.

The Pharmaceutical API Manufacturing Global Market Report 2023 covers regional data on pharmaceutical API manufacturing market size, pharmaceutical API manufacturing market trends and drivers, opportunities, strategies, and pharmaceutical API manufacturing market competitor analysis. The countries covered in the pharmaceutical API manufacturing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Pharmaceutical active pharmaceutical ingredients (API) manufacturing refers to the production of the active substances that give a pharmaceutical medicine its desired impact on the body to treat a condition. Chemical components must be processed in order to make APIs. A biologic drug’s active component is referred to as a bulk process intermediate.

View More Reports Related To The Pharmaceutical API Manufacturing Market –
Pharmaceutical Drugs Global Market Report 2023
Pharmaceutical Processing Seals Global Market Report 2023
Pharmaceutical Excipients Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: